Canada Spends Logo

Explore our Budget 2026 analysis

Grant: Master's Award: Canada Graduate Research Scholarships - Master's program

University of Toronto

$27,000.00

Identification of Anti-fibrotic Signalling Systems that Regulate Intracellular Collagen Degradation

FY 2025-26

Summary
Fibrosis is a high-prevalence disorder that effects multiple organs and is a major health care challenge with limited effective treatments. Fibrosis is characterized by excessive accumulation and stiffening of collagen, which can lead to organ failure. Collagen is the most abundant protein in the non-cellular component of connective tissue which provides structure and support to healthy tissues. In health, cells within connective tissues called fibroblasts, produce and degrade collagen. Fibroblasts may also convert into a modified cell type called a myofibroblast, which contributes to excessive collagen production. In fibrotic tissues, the breakdown of collagen by fibroblasts is decreased. This critical process leads to excessive collagen accumulation, but the mechanism that controls this process is unknown. Notably, activation of a G-protein coupled protein receptor (GPCR) pathway is known to reduce fibrosis by promoting collagen degradation. But fibrosis signaling is complex, so finding drugs that can target myofibroblast conversion and increase collagen degradation are needed. In my research proposal, I will examine whether the GPCR pathway can reverse myofibroblast conversion and thereby enhance collagen breakdown. To test this hypothesis, I will induce myofibroblast activation and then treat fibroblasts with activating GPCR pathway drugs. I will measure myofibroblast conversion by assessing mRNA and protein levels of genes that are myofibroblast markers. I will examine whether activation of the GPCR pathway induces collagen degradation and encourages reversion of myofibroblasts back into fibroblasts. Data from these experiments will suggest potential therapeutics that halt or reverse fibrosis progression.
Program
Master's Award: Canada Graduate Research Scholarships - Master's program
Location
Ontario, Canada
Recipient Type
Academia
Type
Grant
Source
CIHR Funding Decisions Database

As published

Id
573158
Name
Di Raimo Connie M
Region
Ontario
Country
Canada
Orgtype
Institution Paid; Research Institution
Prcname2
Special Cases - Awards Programs
Projecttitle
Identification of Anti-fibrotic Signalling Systems that Regulate Intracellular Collagen Degradation
Programtype2
Studentship Programs
Orgnameinp2
University of Toronto
Cihramount2
$27,000
Cihrequipment2
$0
Programname2
Master's Award: Canada Graduate Research Scholarships - Master's program
Keyworddelim
Calcium Signaling; Collagen Phagocytosis; Cyclic Adenosine Monophosphate; Extracellular Matrix; Fibrosis; G-Protein Coupled Receptors; Intracellular Collagen Degradation; Myofibroblast; Signal Transduction; Transient Receptor Potential Vanilloid 4
Abstract
Fibrosis is a high-prevalence disorder that effects multiple organs and is a major health care challenge with limited effective treatments. Fibrosis is characterized by excessive accumulation and stiffening of collagen, which can lead to organ failure. Collagen is the most abundant protein in the non-cellular component of connective tissue which provides structure and support to healthy tissues. In health, cells within connective tissues called fibroblasts, produce and degrade collagen. Fibroblasts may also convert into a modified cell type called a myofibroblast, which contributes to excessive collagen production. In fibrotic tissues, the breakdown of collagen by fibroblasts is decreased. This critical process leads to excessive collagen accumulation, but the mechanism that controls this process is unknown. Notably, activation of a G-protein coupled protein receptor (GPCR) pathway is known to reduce fibrosis by promoting collagen degradation. But fibrosis signaling is complex, so finding drugs that can target myofibroblast conversion and increase collagen degradation are needed. In my research proposal, I will examine whether the GPCR pathway can reverse myofibroblast conversion and thereby enhance collagen breakdown. To test this hypothesis, I will induce myofibroblast activation and then treat fibroblasts with activating GPCR pathway drugs. I will measure myofibroblast conversion by assessing mRNA and protein levels of genes that are myofibroblast markers. I will examine whether activation of the GPCR pathway induces collagen degradation and encourages reversion of myofibroblasts back into fibroblasts. Data from these experiments will suggest potential therapeutics that halt or reverse fibrosis progression.
Competitiondate
202512
Approvedterm2
1 yr 0 mth
Pinamesdelim
Di Raimo, Connie M
Approvedterm
1 an 0 mois
Cihrcontribution2
~ $27,000~ $0~